These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [From gene defect to drug therapy for obesity?]. Grünewald-Funk D Dtsch Med Wochenschr; 2003 May; 128(19):1034. PubMed ID: 12807110 [No Abstract] [Full Text] [Related]
4. Knockout models resulting in the development of obesity. Butler AA; Cone RD Trends Genet; 2001 Oct; 17(10):S50-4. PubMed ID: 11585677 [TBL] [Abstract][Full Text] [Related]
5. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity. Zemel MB; Shi H Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325 [TBL] [Abstract][Full Text] [Related]
6. [The central melanocortin system and its role in energy homeostasis]. Cone RD Ann Endocrinol (Paris); 1999 Mar; 60(1):3-9. PubMed ID: 10374010 [TBL] [Abstract][Full Text] [Related]
7. [Monogenic forms of obesity: from mice to human]. Clément K Ann Endocrinol (Paris); 2000 Dec; 61 Suppl 6():39-49. PubMed ID: 11148335 [TBL] [Abstract][Full Text] [Related]
8. [Something new in the genetics of monogenic obesity and its insights into pathophysiology]. Baron M; Froguel P; Bonnefond A Med Sci (Paris); 2020 Oct; 36(10):859-865. PubMed ID: 33026327 [TBL] [Abstract][Full Text] [Related]
9. Monogenic disorders of obesity and body fat distribution. Chen D; Garg A J Lipid Res; 1999 Oct; 40(10):1735-46. PubMed ID: 10508193 [TBL] [Abstract][Full Text] [Related]
10. Clinical review 127: Obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. Wardlaw SL J Clin Endocrinol Metab; 2001 Apr; 86(4):1442-6. PubMed ID: 11297566 [No Abstract] [Full Text] [Related]
11. The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. Yeo GS; Farooqi IS; Challis BG; Jackson RS; O'Rahilly S QJM; 2000 Jan; 93(1):7-14. PubMed ID: 10623776 [TBL] [Abstract][Full Text] [Related]
12. Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity. Farooqi IS; O'Rahilly S Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):569-77. PubMed ID: 18779842 [TBL] [Abstract][Full Text] [Related]
13. Knockout studies defining different roles for melanocortin receptors in energy homeostasis. Butler AA; Cone RD Ann N Y Acad Sci; 2003 Jun; 994():240-5. PubMed ID: 12851322 [TBL] [Abstract][Full Text] [Related]
14. [Genetic abnormalities of regulatory mechanism of appetite]. Arai K; Shibasaki T Nihon Rinsho; 2001 Mar; 59(3):449-55. PubMed ID: 11268592 [TBL] [Abstract][Full Text] [Related]
16. [Obesity based on mutation of genes involved in energy balance]. Hainerová I Cas Lek Cesk; 2007; 146(3):240-5. PubMed ID: 17419307 [TBL] [Abstract][Full Text] [Related]
17. Updates on Monogenic Obesity in a Multifactorial Disease. Baxter J; Armijo PR; Flores L; Krause C; Samreen S; Tanner T Obes Surg; 2019 Dec; 29(12):4077-4083. PubMed ID: 31641982 [TBL] [Abstract][Full Text] [Related]
19. The human genetics of eating disorders lessons from the leptin/melanocortin system. Costa JL; Brennen MB; Hochgeschwender U Child Adolesc Psychiatr Clin N Am; 2002 Apr; 11(2):387-97. PubMed ID: 12109327 [TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology and genetics of obesity]. Oberkofler H; Krempler F; Patsch W Wien Klin Wochenschr; 2002; 114 Suppl 4():4-9. PubMed ID: 15499992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]